Biotech Values

[jbog]

Merck has GT1B approval in EU so we'll see what happens. It seems to me that the big buyers don't currently care about 6 week, 8 week or 12 weeks duration nor the dosage type. They want to cure as many as cheaply as possible and get the press off their backs.